The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

76 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain.EBI
The University of Newcastle
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.EBI
Jagiellonian University Medical College
Multitarget opioid ligands in pain relief: New players in an old game.EBI
University of Catania
Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.EBI
The University of Kansas
Potency enhancement of theż-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif.EBI
University of Kansas Specialized Chemistry Center
Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.EBI
Universit£
Novel cyclic biphalin analogue with improved antinociceptive properties.EBI
Universit£
Development of¿ opioid receptor antagonists.EBI
Research Triangle Institute
Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors.EBI
University of Maryland
Ligand binding to nucleic acids and proteins: Does selectivity increase with strength?EBI
Universit£T Des Saarlandes
Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor.EBI
University of Minnesota
Effect of a 6-cyano substituent in 14-oxygenated N-methylmorphinans on opioid receptor binding and antinociceptive potency.EBI
University of Innsbruck
Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic.EBI
University of Innsbruck
Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.EBI
Research Triangle Institute
Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the"address" recognition locus.EBI
University of Minnesota
Transformation of a kappa-opioid receptor antagonist to a kappa-agonist by transfer of a guanidinium group from the 5'- to 6'-position of naltrindole.EBI
University of Minnesota
Isosteric replacement of acidic with neutral residues in extracellular loop-2 of the kappa-opioid receptor does not affect dynorphin A(1-13) affinity and function.EBI
University of Minnesota
Modeling of kappa-opioid receptor/agonists interactions using pharmacophore-based and docking simulations.EBI
Universit£
Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors.EBI
University of Minnesota
Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes.EBI
University of Minnesota
3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy.EBI
University of Bristol
Cyclic enkephalin analogues containing alpha-amino-beta-mercapto-beta,beta-pentamethylenepropionic acid at positions 2 or 5.EBI
Smith Kline and French Laboratories
N-substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines.EBI
TBA
ORL1 receptor ligands: structure-activity relationships of 8-cycloalkyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-ones.EBI
F. Hoffmann-La Roche
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole.EBI
University of Maryland
Syntheses of potent Leu-enkephalin analogs possessing beta-hydroxy-alpha,alpha-disubstituted-alpha-amino acid and their characterization to opioid receptors.EBI
Institute For Bioorganic Research
 
Synthesis and biological evaluation of 14-alkoxymorphinans. 14.1 14-ethoxy-5-methyl substituted indolomorphinans with opioid receptor selectivityEBI
TBA
Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2.EBI
Sapienza University of Rome
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.EBI
Università
Synthesis and evaluation of opioid receptor-binding affinity of elaeocarpenine and its analogs.EBI
Kyorin Pharmaceutical
Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.EBI
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School and The Informatics Institute of Umdnj
The effects of C-terminal modifications on the opioid activity of [N-benzylTyr(1)]dynorphin A-(1-11) analogues.EBI
University of Kansas
Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis.EBI
The University of Kansas
 
trans N-Methyl-N-[2-(1-pyrrolidinyl)cyclohexyl] cycloprop-2-ene-1-carboxamides: Novel lipophilic kappa opioid agonistsEBI
TBA
 
Stereoselective synthesis and evaluation of all stereoisomers of Z4349, a novel and selective μ-opioid analgesicEBI
TBA
Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.EBI
University of Mississippi
Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources.EBI
TBA
Structure-Activity Studies of 1EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.EBI
The University of Melbourne
Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.EBI
University of Innsbruck
Novel Cyclic Endomorphin Analogues with Multiple Modifications and Oligoarginine Vector Exhibit Potent Antinociception with Reduced Opioid-like Side Effects.EBI
Harbin Institute of Technology
Structure-activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues.EBI
Biological Research Center of The Hungarian Academy of Sciences
Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.EBI
University of Maryland
Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.EBI
University of Maryland
Mechanism of action of the diazabicyclononanone-type kappa-agonists.EBI
UniversitäT WüRzburg
Opioid activity of 4-imidazolidinone positional analogues of Leu-Enkephalin.EBI
Institute For Molecular Studies
3-Pyrroline containing arylacetamides: a novel series of remarkably selective kappa-agonists.EBI
Chinese Academy of Sciences
Design, synthesis, and biological activity of new endomorphin analogs with multi-site modifications.EBI
Lanzhou University
Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists.EBI
Astrazeneca
Potent and selective indolomorphinan antagonists of the kappa-opioid receptor.EBI
University of Minnesota
An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain.EBI
University of Catania
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.EBI
Shanghaitech University
Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists.EBI
Eisai
Conformationally constrained deltorphin analogs with 2-aminotetralin-2-carboxylic acid in position 3.EBI
Hungarian Academy of Sciences
Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives.EBI
Solvay Duphar
Enkephalin analogs as systemically active antinociceptive agents: O- and N-alkylated derivatives of the dipeptide amide L-2,6-dimethyltyrosyl-N-(3-phenylpropyl)-D-alaninamide.EBI
Searle
Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl).EBI
University of Kansas
Modulation of opioid receptor affinity and efficacy via N-substitution of 9?-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.EBI
National Institute On Drug Abuse and The National Institute On Alcohol Abuse
Preparation and opioid activity of analogues of the analgesic dipeptide 2,6-dimethyl-L-tyrosyl-N-(3-phenylpropyl)-D-alaninamide.EBI
G.D. Searle And
Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening.BDB
Icahn School of Medicine At Mount Sinai
Novel 4-heteroaryl-antipyrines as DPP-IV inhibitors.BDB
Cairo University
Characterisation of melanocortin receptor subtypes by radioligand binding analysis.BDB
Uppsala